NDC 62037-964-25 - Tamoxifen Citrate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 62037-964
- Requested NDC
- 62037-964-25
- Package NDCs from labels
- 62037-964-60, 62037-964-18, 62037-964-25
- Manufacturer
- Andrx Pharmaceuticals, Inc.
- Effective date
- 2007-04-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TAMOXIFEN CITRATE TABLETS, USP | Andrx Pharmaceuticals, Inc. | 2007-04-20 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 62037-964-18 | Tamoxifen Citrate | 180 in 1 BOTTLE, PLASTIC | TABLET | 180 | 1 | |
| 62037-964-25 | Tamoxifen Citrate | 2500 in 1 BOTTLE, PLASTIC | TABLET | 2500 | 1 | |
| 62037-964-60 | Tamoxifen Citrate | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Tamoxifen Citrate | ACTIVE INGREDIENT | 7FRV7310N6 | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 | |
| Tamoxifen | ACTIVE MOIETY | 094ZI81Y45 | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 | |
| carboxymethylcellulose calcium | INACTIVE INGREDIENT | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 | ||
| magnesium stearate | INACTIVE INGREDIENT | 70097M6I30 | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 | |
| starch | INACTIVE INGREDIENT | TAMOXIFEN CITRATE (TAMOXIFEN CITRATE) TABLET [ANDRX PHARMACEUTICALS, INC.] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tamoxifen Citrate | TAMOXIFEN CITRATE | NuCare Pharmaceuticals, Inc. | 509f8ba3-214d-aec8-e063-6294a90af498 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | 8c0eb763-420a-4106-ba56-526b53a7f72b | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 8d731e7e-3b04-49a2-a0f6-3779422174cc | 2026-03-19 | Boxed warning, Warnings, Adverse reactions | 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Actavis Pharma, Inc. | 9b8a4211-120f-4981-ad69-928accb97637 | 2025-12-18 | Boxed warning, Warnings, Adverse reactions | 313195 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Mayne Pharma Commercial LLC | c82205a3-ae0c-4ce5-b04b-9581cd8c70d4 | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 313195 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | A-S Medication Solutions | 716657e8-d809-4671-87bc-8d10ef69a071 | 2025-11-06 | Boxed warning, Warnings, Adverse reactions | 313195 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | 9b4a8abc-6e56-40c5-a826-1d1f3c0786e1 | 2024-11-07 | Boxed warning, Warnings, Adverse reactions | 313195 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | NuCare Pharmaceuticals,Inc. | a5615dbb-3c5e-6ccc-e053-2995a90ab698 | 2024-07-17 | Boxed warning, Warnings, Adverse reactions | 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Dr. Reddy's Labratories Inc. | c6c6a643-57d6-7ea5-7da0-e8a66802468a | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 313195 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Bryant Ranch Prepack | feb96056-79f5-4024-ab0e-fdbb8d4ab862 | 2024-01-19 | Boxed warning, Warnings, Adverse reactions | 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Proficient Rx LP | bb53eeb7-83fc-469e-b9e3-df5f27bfec7b | 2022-09-01 | Boxed warning, Warnings, Adverse reactions | 313195 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Mylan Pharmaceuticals Inc. | 7ee3d3d2-85d1-4018-8e70-5ed8a64ae1f0 | 2021-07-02 | Boxed warning, Warnings, Adverse reactions | 313195 198240 |
| Tamoxifen Citrate | TAMOXIFEN CITRATE | Aurobindo Pharma Limited | a596c715-8e30-43c1-aba3-4fe5de6729fa | 2020-08-14 | Boxed warning, Warnings, Adverse reactions | 313195 198240 |
| 741AE689-9A31-2CAB-5A68-4BA650BE4EFB | 8f642753-9e12-433c-a0bc-ab33dac41ddf | 2007-04-20 | Boxed warning, Warnings, Adverse reactions | 741AE689-9A31-2CAB-5A68-4BA650BE4EFB 8f642753-9e12-433c-a0bc-ab33dac41ddf |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.